Nasal administration of recombinant osteopontin attenuates early brain injury after subarachnoid hemorrhage. [electronic resource]
Producer: 20131220Description: 3189-94 p. digitalISSN:- 1524-4628
- Administration, Intranasal
- Animals
- Apoptosis
- Brain -- pathology
- Brain Injuries -- complications
- Caspase 3 -- metabolism
- Focal Adhesion Kinase 1 -- metabolism
- Male
- Neurons -- pathology
- Osteopontin -- therapeutic use
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-akt -- metabolism
- Rats
- Rats, Sprague-Dawley
- Recombinant Proteins -- therapeutic use
- Subarachnoid Hemorrhage -- complications
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.